Noema Pharma raises CHF54 million in Series A financing round: the advisors

Noema Pharma, a Swiss clinical-stage company targeting orphan neurological disorders, announced it has successfully concluded an oversubscribed Series A financing round, raising CHF54 million ($59 million USD) to fund further development of its promising clinical-stage pipeline. The round was co-led by Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, and Polaris Partners, a healthcare and technology investment firm based in the United States. The global consortium of new international investors includes Gilde Healthcare, Invus and BioMed Partners. Roche, the Swiss multinational healthcare company, received a shareholding in Noema in exchange for rights to four clinical-stage product-candidates.

The advisors

 

VISCHER is advising Noema Pharma in this transaction. The team is led by Matthias Staehelin (Corporate, pictured left) with Christian Wyss (Corporate), Nadia Tarolli (Tax), Vincent Reardon (Corporate) and Pauline Pfirter (Corporate).

Walder Wyss advised Gilde Healthcare Partners, Polaris Partners, Invus Capital and BioMedInvest as investors on the CHF 54m series A financing of Noema Pharma. The team included Alexander Gutmans (Partner, Corporate/M&A and Venture Capital – pictured right), Robert von Rosen (Partner, Corporate/M&A and Venture Capital), Markus R. Frick (Partner, IP/IT) and Karina Tschon (Associate, Corporate/M&A and Venture Capital).

Noema Pharma raises CHF54 million in Series A financing round: the advisors

FabioAdmin

Legalcommunity.ch

Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio

SHARE

Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram